Dr. Ihab Mohammed Deebajah, MD Internal Medicine - Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 6255 Inkster Rd, Suite 204, Garden City, MI 48135 Phone: 734-524-0950 Fax: 734-524-0951 |
News Archive
Alnylam Pharmaceuticals, Inc., a leading RNAi therapeutics company, announced today final results from its completed Phase I clinical trial with ALN-TTR01, an RNAi therapeutic targeting transthyretin (TTR) for the treatment of TTR-mediated amyloidosis.
While many people have an opinion on whether animals can help to improve wellbeing and care for patients in hospitals, does anyone really know whether there are benefits both for the patients and the animals themselves?
A new report from Chile – currently available on the medRxiv* preprint server – reveals how mutations in the spike glycoprotein of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) Lambda variant can confer protection from neutralizing antibodies and increase viral infectivity rates, which means massive vaccination campaigns should be accompanied by strict genomic surveillance.
Baylor Health Care System and Select Medical Corporation announced today a proposed partnership between Baylor Institute for Rehabilitation and a wholly-owned subsidiary of Select that is designed to create a regional rehabilitation network to serve the Dallas-Fort Worth metroplex. This joint venture is subject to governmental approvals and it is anticipated that the joint venture will be approved and finalized within the normal process for governmental review.
› Verified 9 days ago